Akt2 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Products
AKT2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Anti-AKT2 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
Anti-AKT2 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
CNY 5973.00
5周
AKT2 (specific) (incl. pos. control) mouse monoclonal antibody, clone 8B7, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
AKT2 PE Antibody
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
AKT2 APC Antibody
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
AKT2 APC Antibody
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
AKT2 rabbit polyclonal antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
AKT2 rabbit polyclonal antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Clonalities
Assay Types
Brands
QC Levels
Pathways
- Acute myeloid leukemia (41)
- Adipocytokine signaling pathway (41)
- Apoptosis (41)
- B cell receptor signaling pathway (41)
- Chemokine signaling pathway (41)
- Chronic myeloid leukemia (41)
- Colorectal cancer (41)
- Endometrial cancer (41)
- ErbB signaling pathway (41)
- Fc epsilon RI signaling pathway (41)
- Fc gamma R-mediated phagocytosis (41)
- Focal adhesion (41)
- Glioma (41)
- Insulin signaling pathway (41)
- Jak-STAT signaling pathway (41)
- MAPK signaling pathway (41)
- Melanoma (41)
- Neurotrophin signaling pathway (41)
- Non-small cell lung cancer (41)
- Pancreatic cancer (41)
- Pathways in cancer (41)
- Progesterone-mediated oocyte maturation (41)
- Prostate cancer (41)
- Renal cell carcinoma (41)
- Small cell lung cancer (41)
- T cell receptor signaling pathway (41)
- Tight junction (41)
- Toll-like receptor signaling pathway (41)
- VEGF signaling pathway (41)
- mTOR signaling pathway (41)
